Researchers from across all academic disciplines at Indiana University Bloomington will present information about projects that have potential commercial applications at the second annual Bloomington Innovation Conference on March 31.
The Johnson Center for Innovation and Translational Research organizes the event, which will take place 9 a.m. to 6:30 p.m. EDT in the Frangipani Room and Georgian Room, Indiana Memorial Union, Biddle Hotel and Conference Center, 900 E. Seventh St., Bloomington. Attendance is limited, and registration is required.
JCITR works with faculty and researchers throughout the IU Bloomington campus to identify discoveries that hold commercial potential and protect intellectual property. It also assists with grant applications, identifying industry partners, negotiating industry contracts, project-management support and increased use of core IU facilities by industry partners. Director Keith R. Davis believes researchers will benefit by attending the conference.
“Presenters will have the opportunity to receive valuable feedback on their work through discussions with attendees from both the Bloomington campus and regional industry partners,” Davis said. “We see this conference as a key activity of the JCITR and hope we can foster more industry-academic collaborations in Bloomington.”
Scheduled speakers include Michael Hiles, vice president for research and development and chief scientific officer, Cook Biotech Inc.; Maria J. Blanco, director, discovery chemistry research & technologies, Eli Lilly & Co.; Adam Zlotnick, professor, Department of Molecular and Cellular Biochemistry and co-founder, Assembly Biosciences; and IU innovators who received funding through the JCITR Translational Research Pilot Grant Program.